The combination drug valsartan/sacubitril (LCZ696) reduced pulse wave velocity and aortic systolic blood pressure in patients with stable heart failure with reduced ejection fraction

被引：0
|
作者：
Kobalava, Z. [1 ]
Villevalde, S. [1 ]
Tyukhmenev, E. [1 ]
Lukina, O. Olga [1 ]
Babaeva, L. [1 ]
Zharikova, E. [1 ]
机构：
[1] Peoples Friendship Univ Russia, Moscow, Russia
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2016年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1466
引用
收藏
页码：335 / 335
页数：1
相关论文
共 50 条
  • [41] Use and Benefit of Sacubitril/Valsartan in Elderly Patients with Heart Failure with Reduced Ejection Fraction
    Roca, Luis Nieto
    Garcia, Marcelino Cortes
    German, Jorge Balaguer
    Becerra, Antonio Jose Bollas
    Otero, Jose Maria Romero
    Chapel, Jose Antonio Esteban
    Lopez, Carlos Rodriguez
    Lazaro, Ana Maria Pello
    Urquia, Mikel Taibo
    Tunon, Jose
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (16)
  • [42] Left Ventricular Ejection Fraction Recovery in Patients with Heart Failure and Reduced Ejection Fraction Treated with Sacubitril/Valsartan
    Diez-Villanueva, Pablo
    Vicent, Lourdes
    de la Cuerda, Francisco
    Esteban-Fernandez, Alberto
    Gomez-Bueno, Manuel
    de Juan-Baguda, Javier
    Manuel Iniesta, Angel
    Ayesta, Ana
    Rojas-Gonzalez, Antonio
    Bover-Freire, Ramon
    Iglesias, Diego
    Garcia-Aguado, Marcos
    Angel Perea-Egido, Jesus
    Salamanca, Jorge
    Martinez-Selles, Manuel
    CARDIOLOGY, 2020, 145 (05) : 275 - 282
  • [43] Improvement of left ventricular systolic performance during sacubitril/valsartan in a cohort of patients with heart failure and reduced ejection fraction
    Monosilio, Sara
    Filomena, Domenico
    Cimino, Sara
    Neccia, Matteo
    Luongo, Federico
    Mariani, Marco
    Birtolo, Lucia Ilaria
    Benedetti, Giulia
    Maestrini, Viviana
    Agati, Luciano
    Fedele, Francesco
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0N) : N40 - N40
  • [44] Economic evaluation of sacubitril/valsartan for the treatment of heart failure with reduced ejection fraction
    Stafylas, P.
    Farmakis, D.
    Giamouzis, G.
    Hatzikou, M.
    Kourlaba, G.
    Papatsouma, I.
    Maniadakis, N.
    EUROPEAN HEART JOURNAL, 2016, 37 : 730 - 731
  • [45] Focused Treatment of Heart Failure with Reduced Ejection Fraction Using Sacubitril/Valsartan
    Rex C. Liu
    American Journal of Cardiovascular Drugs, 2018, 18 : 473 - 482
  • [46] Acute pulmonary pressure change after transition to sacubitril/valsartan in patients with heart failure reduced ejection fraction
    Tran, Jeffrey S.
    Havakuk, Ofer
    Mcleod, Jennifer
    Hwang, Jennifer
    Kwong, Hoi Yan
    Shavelle, David
    Zile, Michael R.
    Elkayam, Uri
    Fong, Michael W.
    Grazette, Luanda P.
    ESC HEART FAILURE, 2021, 8 (02): : 1706 - 1710
  • [47] Sacubitril/Valsartan in the primary treatment of heart failure with reduced ejection fraction (HFrEF)
    Nowak, Bernd
    Geiss, Ernst
    Boehm, Michael
    Weil, Joachim
    Boer, Jana
    KARDIOLOGIE, 2023, : 44 - 48
  • [48] Safety and tolerability of Sacubitril/Valsartan in heart failure patient with reduced ejection fraction
    Khan, Muhammad Nauman
    Soomro, Najia Aslam
    Naseeb, Khalid
    Bhatti, Usman Hanif
    Rauf, Rubina
    Balouch, Iram Jehan
    Moazzam, Ali
    Bashir, Sonia
    Ashraf, Tariq
    Karim, Musa
    BMC CARDIOVASCULAR DISORDERS, 2023, 23 (01)
  • [49] Sacubitril/valsartan reduces ventrucular arrhythmias in heart failure with reduced ejection fraction
    Lamaida, Norman
    Torella, Giorgio
    Cerciello, Antonio
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0N) : N26 - N26
  • [50] Current evidence of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction
    Abumayyaleh, Mohammad
    El-Battrawy, Ibrahim
    Behnes, Michael
    Borggrefe, Martin
    Akin, Ibrahim
    FUTURE CARDIOLOGY, 2020, 16 (04) : 227 - 236
12345